查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947500

药物筛检市场：依产品类型、样本类型、技术、最终用户和应用划分－全球预测至2036年

Drug Screening Market by Product, Sample Type, Technology, End User, and Application -- Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 284 Pages | 商品交期: 5-7个工作天内

价格
简介目录

全球药物筛检市场预计将从2026年的82.9亿美元成长到2036年的约253亿美元，预测期内（2026-2036年）复合年增长率（CAGR）为11.8%。

本报告对全球五大主要地区的药物筛检市场进行了详细分析，重点关注当前市场趋势、市场规模、近期发展以及至2036年的预测。透过广泛的二级和一级研究以及对市场现状的深入分析，我们分析了关键产业驱动因素、限制因素、机会和挑战的影响。

推动药物筛检市场成长的关键因素包括：全球对工作场所安全的日益关注、综合药物滥用预防计画的快速扩展，以及交通运输和医疗机构对可靠检测方法的需求不断增长。 此外，口腔液检测的广泛应用、快速检测系统的创新以及监管合规基础设施的完善，预计将为药物筛检市场的企业创造巨大的成长机会。

市场区隔

目录

第一章：引言

第二章：摘要整理

第三章：市场概览

  • 市场动态
    • 驱动因素
    • 限制因素
    • 机遇
    • 挑战
  • 监管变化和合成物质对药物筛检的影响
  • 监管环境与联邦检测标准
  • 波特五力分析

章节4. 全球药物筛检市场（依产品类型划分）

  • 分析仪器
    • 免疫分析仪
    • 色谱仪
    • 质谱系统
  • 快速侦测仪器
    • 尿液检测试剂盒
    • 口腔液检测仪器
    • 检测杯和浸渍卡
  • 耗材
    • 检测试剂盒和试剂
    • 采样装置
    • 校准品和品管品
  • 服务
    • 实验室服务
    • 工作场所检测项目
    • 确证分析服务

第五章：全球药物筛检市场（依样本类型划分）

  • 尿液样本
  • 口腔液样本
  • 呼吸样本
  • 毛髮样本
  • 其他（血液、汗水）

第六章 全球药物筛检市场（依技术划分）

  • 免疫分析法
    • 酵素连结免疫分析法
    • 放射免疫分析法
    • 萤光免疫分析法
  • 色谱法
    • 气相层析质谱仪用法
    • 液相层析质谱仪用法
    • 高效液相层析法
  • 呼吸分析仪
    • 燃料电池技术
    • 半导体技术
  • 其他（光谱学、晶片实验室）

第七章：全球药物筛检市场（依最终使用者划分）

  • 工作场所
    • 入职前筛检
    • 随机检测项目
    • 事故后侦测
  • 药物检测实验室
  • 医院和诊所
  • 刑事司法与执法机构
  • 戒毒治疗中心
  • 疼痛管理中心
  • 学校和教育机构
  • 其他（体育组织、个人使用者）

第八章：全球药物筛检市场（依应用划分）

  • 药物滥用检测
    • 大麻检测
    • 阿片类药物检测
    • 可卡因检测
    • 安非他明检测检测
    • 合成药物检测
  • 酒精检测
  • 其他（处方药监测、运动兴奋剂）

第九章 全球药物筛检市场（依地区划分）

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
    • 东南亚
    • 亚太其他地区
  • 拉丁美洲美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非
    • 中东和非洲其他地区

第十章 竞争格局

  • 关键成长策略
  • 竞争标竿分析
  • 竞争概览
    • 行业领导者
    • 市场差异化因素
    • 先锋企业
    • 新兴企业
  • 主要企业市场排名/定位分析（2025 年）

第11章 企业简介(产业概要，财务概要，产品系列，策略性展开，SWOT分析)

  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings(LabCorp)
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Dragerwerk AG &Co. KGaA
  • OraSure Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Lifeloc Technologies, Inc.
  • Premier Biotech, Inc.
  • Omega Laboratories, Inc.
  • Psychemedics Corporation
  • Alfa Scientific Designs, Inc.
  • MPD Inc.

第12章 附录

简介目录
Product Code: MRHC - 1041763

Drug Screening Market by Product (Analyzers, Rapid Testing Devices, Consumables, Services), Sample Type (Urine, Oral Fluid, Breath, Hair), Technology (Immunoassay, Chromatography, Breath Analyzers), End User (Workplace, Drug Testing Laboratories, Hospitals, Criminal Justice, Drug Treatment Centers), and Application (Drug of Abuse Testing, Alcohol Testing) - Global Forecast to 2036

According to the research report titled, 'Drug Screening Market by Product (Analyzers, Rapid Testing Devices, Consumables, Services), Sample Type (Urine, Oral Fluid, Breath, Hair), Technology (Immunoassay, Chromatography, Breath Analyzers), End User (Workplace, Drug Testing Laboratories, Hospitals, Criminal Justice, Drug Treatment Centers), and Application (Drug of Abuse Testing, Alcohol Testing) - Global Forecast to 2036,' the global drug screening market is expected to reach approximately USD 25.3 billion by 2036 from USD 8.29 billion in 2026, at a CAGR of 11.8% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global drug screening market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The major factors driving the growth of the drug screening market include escalating global concern over workplace safety, rapid expansion of comprehensive substance abuse prevention programs, and increasing need for high-reliability detection in transportation and healthcare complexes. Additionally, proliferation of oral fluid testing, innovation in rapid testing systems, and regulatory compliance infrastructure development are expected to create significant growth opportunities for players operating in the drug screening market.

Market Segmentation

The drug screening market is segmented by product (analyzers, rapid testing devices, consumables, services), sample type (urine, oral fluid, breath, hair), technology (immunoassay, chromatography, breath analyzers), end user (workplace, drug testing laboratories, hospitals, criminal justice, drug treatment centers), application (drug of abuse testing, alcohol testing), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Product

By product, the services segment holds the largest market share in 2026, particularly in supporting large-scale laboratory testing operations, comprehensive workplace programs, and superior analytical accuracy in forensic applications. Analyzers represent a significant segment for confirmatory testing and high-volume screening. Rapid testing devices are growing rapidly for point-of-care applications and on-site screening. Consumables represent a steady segment supporting ongoing testing operations.

Based on Sample Type

By sample type, the urine sample segment holds the largest market share in 2026, due to the widespread adoption of standardized testing protocols and established detection windows for diverse substance categories. Oral fluid represents a rapidly growing segment offering improved sample integrity and non-invasive collection. Breath and hair samples represent specialized segments for specific applications and extended detection windows.

Based on Technology

By technology, immunoassay dominates the market for rapid screening applications, offering cost-effectiveness and high-throughput capabilities. Chromatography represents a significant segment for confirmatory testing and complex substance detection. Breath analyzers represent a specialized segment for alcohol testing and impairment assessment. Advanced analytical technologies continue to evolve for improved detection accuracy and expanded substance coverage.

Based on End User

By end user, the workplace segment holds the largest share of the overall market in 2026, driven by stringent regulatory requirements and comprehensive occupational health protocols. Drug testing laboratories represent a significant segment for confirmatory testing and forensic applications. Hospitals, criminal justice systems, and drug treatment centers represent growing segments with specialized testing requirements and regulatory compliance needs.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America dominates the global drug screening market with the largest market share in 2026, driven by stringent workplace regulations and the presence of comprehensive federal testing programs in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by increasing awareness of substance abuse prevention and expanding workplace safety protocols in China, India, and Japan.

Key Players

The key players operating in the global drug screening market are Quest Diagnostics, LabCorp, Abbott Diagnostics, Thermo Fisher Scientific, Alere Inc., Roche Diagnostics, Siemens Healthcare Diagnostics, Bio-Rad Laboratories, Immunalysis Corporation, and Psychemedics Corporation, among others.

Key Questions Answered in the Report

  • How big is the global drug screening market?
  • What is the growth rate of the global drug screening market?
  • Which product segment will dominate and grow the fastest?
  • How are oral fluid testing and synthetic substance detection transforming the drug screening landscape?
  • Which region leads the global drug screening market?
  • Who are the major players in the global drug screening market?
  • What are the key trends shaping the drug screening market?
  • What are the major opportunities and challenges in the drug screening market?

Scope of the Report:

Drug Screening Market Assessment -- by Product

  • Analyzers
  • Rapid Testing Devices
  • Consumables
  • Services

Drug Screening Market Assessment -- by Sample Type

  • Urine
  • Oral Fluid
  • Breath
  • Hair

Drug Screening Market Assessment -- by Technology

  • Immunoassay
  • Chromatography
  • Breath Analyzers
  • Others

Drug Screening Market Assessment -- by End User

  • Workplace
  • Drug Testing Laboratories
  • Hospitals
  • Criminal Justice
  • Drug Treatment Centers

Drug Screening Market Assessment -- by Application

  • Drug of Abuse Testing
  • Alcohol Testing

Drug Screening Market Assessment -- by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Southeast Asia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Scope
  • 1.3. Research Methodology
  • 1.4. Assumptions & Limitations

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
    • 3.2.4. Challenges
  • 3.3. Impact of Regulatory Changes and Synthetic Substances on Drug Screening
  • 3.4. Regulatory Landscape & Federal Testing Standards
  • 3.5. Porter's Five Forces Analysis

4. Global Drug Screening Market, by Product

  • 4.1. Introduction
  • 4.2. Analyzers
    • 4.2.1. Immunoassay Analyzers
    • 4.2.2. Chromatography Instruments
    • 4.2.3. Mass Spectrometry Systems
  • 4.3. Rapid Testing Devices
    • 4.3.1. Urine Test Kits
    • 4.3.2. Oral Fluid Test Devices
    • 4.3.3. Test Cups & Dip Cards
  • 4.4. Consumables
    • 4.4.1. Assay Kits & Reagents
    • 4.4.2. Sample Collection Devices
    • 4.4.3. Calibrators & Controls
  • 4.5. Services
    • 4.5.1. Laboratory Testing Services
    • 4.5.2. Workplace Testing Programs
    • 4.5.3. Confirmatory Analysis Services

5. Global Drug Screening Market, by Sample Type

  • 5.1. Introduction
  • 5.2. Urine Sample
  • 5.3. Oral Fluid Sample
  • 5.4. Breath Sample
  • 5.5. Hair Sample
  • 5.6. Others (Blood, Sweat)

6. Global Drug Screening Market, by Technology

  • 6.1. Introduction
  • 6.2. Immunoassay
    • 6.2.1. Enzyme Immunoassay
    • 6.2.2. Radioimmunoassay
    • 6.2.3. Fluorescence Immunoassay
  • 6.3. Chromatography
    • 6.3.1. Gas Chromatography-Mass Spectrometry
    • 6.3.2. Liquid Chromatography-Mass Spectrometry
    • 6.3.3. High-Performance Liquid Chromatography
  • 6.4. Breath Analyzers
    • 6.4.1. Fuel Cell Technology
    • 6.4.2. Semiconductor Technology
  • 6.5. Others (Spectroscopy, Lab-on-a-Chip)

7. Global Drug Screening Market, by End User

  • 7.1. Introduction
  • 7.2. Workplace
    • 7.2.1. Pre-employment Screening
    • 7.2.2. Random Testing Programs
    • 7.2.3. Post-accident Testing
  • 7.3. Drug Testing Laboratories
  • 7.4. Hospitals & Clinics
  • 7.5. Criminal Justice & Law Enforcement Agencies
  • 7.6. Drug Treatment Centers
  • 7.7. Pain Management Centers
  • 7.8. Schools & Educational Institutions
  • 7.9. Others (Sports Organizations, Personal Users)

8. Global Drug Screening Market, by Application

  • 8.1. Introduction
  • 8.2. Drug of Abuse Testing
    • 8.2.1. Cannabis/Marijuana Testing
    • 8.2.2. Opioid Testing
    • 8.2.3. Cocaine Testing
    • 8.2.4. Amphetamine Testing
    • 8.2.5. Synthetic Drug Testing
  • 8.3. Alcohol Testing
  • 8.4. Others (Prescription Drug Monitoring, Sports Doping)

9. Global Drug Screening Market, by Region

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Netherlands
    • 9.3.7. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. India
    • 9.4.3. Japan
    • 9.4.4. South Korea
    • 9.4.5. Australia
    • 9.4.6. Southeast Asia
    • 9.4.7. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa
    • 9.6.1. Saudi Arabia
    • 9.6.2. UAE
    • 9.6.3. South Africa
    • 9.6.4. Rest of Middle East & Africa

10. Competitive Landscape

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Ranking / Positioning Analysis of Key Players, 2025

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)

  • 11.1. Quest Diagnostics Incorporated
  • 11.2. Laboratory Corporation of America Holdings (LabCorp)
  • 11.3. Abbott Laboratories
  • 11.4. Thermo Fisher Scientific Inc.
  • 11.5. F. Hoffmann-La Roche Ltd.
  • 11.6. Siemens Healthineers AG
  • 11.7. Dragerwerk AG & Co. KGaA
  • 11.8. OraSure Technologies Inc.
  • 11.9. Bio-Rad Laboratories, Inc.
  • 11.10. Lifeloc Technologies, Inc.
  • 11.11. Premier Biotech, Inc.
  • 11.12. Omega Laboratories, Inc.
  • 11.13. Psychemedics Corporation
  • 11.14. Alfa Scientific Designs, Inc.
  • 11.15. MPD Inc.

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Related Reports